In an unexpected turn in the $86 million patent case against Medtronic, a medical device behemoth, U.S. District Judge Alan Albright declared a mistrial. Taking place in Texas, the proceedings centered around the stents sold by the defendant. The mistrial was called when one of the jurors steadfastly held a position contrary to that of their peers.
The specific details of the disagreement among the jurors have not been made publicly available at this point. It remains unclear what the implications of this mistrial will be for the involved parties, or how it may impact the strategy for potential retrials.
For those interested in deeper insights into this ongoing litigation, more details can be found in the article authored by Andrew Karpan and published on Law360 here.